The Dermatological Drug Delivery section of Frontiers in Drug Delivery publishes high quality basic, applied, translational, and industry research across the field of new technologies and approaches to deliver drugs through or into skin, either for treatment of local disease or systemic release.Read More
The Dermatological Drug Delivery section of Frontiers in Drug Delivery publishes high quality basic, applied, translational, and industry research across the field of new technologies and approaches to deliver drugs through or into skin, either for treatment of local disease or systemic release. Non- or minimally-invasive methods of transdermal drug delivery that offer both convenience and efficiency outweigh the more traditional methods of oral delivery and hypodermic needle drug delivery. The field has progressed well beyond first generation of patches, microneedles and formulations, however, transdermal drug delivery has yet to reach its full potential. Areas covered by this section include, but are not limited to:
A proof-of-concept for new non- or minimally- invasive transdermal drug delivery or drug monitoring technologies;
Modeling or synthetic skin analogs that improve our understanding of drug permeation;
Emerging technologies for transdermal drug delivery or drug monitoring in skin;
Existing drugs that have a new indication for treatment of skin disease;
New formulations that move large and chemically non-compatible molecules across the skin's biological barrier;
Drug-independent technologies used to treat skin diseases or bring about biological changes within skin.
All studies must contribute insights into advances in topical drug delivery, transdermal drug delivery systems or improve our understanding of drug permeation into skin.
Indexed in: Google Scholar, CrossRef, CLOCKSS, OpenAIRE
Dermatological Drug Delivery welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Protocols, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Dermatological Drug Delivery, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com